Immunoassay Market Poised for Significant Growth, Expected to Reach $47.7 Billion by 2030
New York, NY – September 1, 2025 – The global immunoassay market is on a robust growth trajectory, with projections indicating it will reach a substantial $47.7 billion by the year 2030. This significant expansion is driven by a compound annual growth rate (CAGR) of 6.1% over the forecast period, according to a comprehensive new report by MarketsandMarkets™.
The “Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™” report, published by PR Newswire’s Healthring, highlights the increasing demand for sensitive and specific diagnostic tools across various healthcare applications. Immunoassays, which utilize the high specificity of antibody-antigen interactions to detect and quantify substances, play a crucial role in diagnosing diseases, monitoring treatment efficacy, and advancing biomedical research.
Several key factors are contributing to this optimistic market outlook. The rising prevalence of chronic diseases such as cancer, cardiovascular conditions, and infectious diseases worldwide necessitates accurate and early diagnostic methods, where immunoassays excel. Furthermore, the growing global demand for point-of-care testing (POCT) solutions, driven by the need for rapid results and decentralized healthcare, is a significant catalyst for immunoassay adoption.
Technological advancements are also playing a pivotal role. Innovations in immunoassay platforms, including the development of multiplex assays that can detect multiple analytes simultaneously, and the integration of automation and artificial intelligence, are enhancing efficiency and accuracy. The increasing investment in research and development by key market players is further fueling the introduction of novel and improved immunoassay technologies.
The report by MarketsandMarkets™ likely delves into the segmentation of the market by product type, technology, application, end-user, and region. Understanding these segments will provide a clearer picture of the specific areas driving growth. For instance, the market for immunoassay reagents and kits is expected to remain a dominant segment due to their widespread use in both research and clinical diagnostics.
Geographically, North America and Europe are anticipated to hold significant market shares, owing to advanced healthcare infrastructure, higher healthcare expenditure, and strong research capabilities. However, the Asia-Pacific region is projected to witness the fastest growth, fueled by increasing healthcare awareness, rising disposable incomes, and a growing number of diagnostic laboratories.
In conclusion, the immunoassay market is set for a period of substantial expansion, driven by the critical role these diagnostic tools play in modern healthcare. The projected $47.7 billion valuation by 2030 underscores the increasing reliance on and innovation within this vital sector of the diagnostics industry. Healthcare providers, researchers, and manufacturers can anticipate continued opportunities and advancements as the market matures.
Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Healthring published ‘Immunoassay Market worth $47.7 billion by 2030 with 6.1% CAGR | MarketsandMarkets™.’ at 2025-09-01 14:01. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.